Article (Scientific journals)
Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis.
Burbulla, Lena F.; Schelling, Carina; Kato, Hiroki et al.
2010In Human Molecular Genetics, 19 (22), p. 4437-52
Peer Reviewed verified by ORBi


Full Text
Publisher postprint (619.72 kB)
Request a copy

All documents in ORBilu are protected by a user license.

Send to


Keywords :
Aged; DNA Topoisomerases, Type II/metabolism; DNA-Binding Proteins/metabolism; Female; Gene Knockdown Techniques; Genetic Variation; HSP70 Heat-Shock Proteins/genetics; Humans; Male; Membrane Potential, Mitochondrial/genetics; Middle Aged; Mitochondria/metabolism/physiology; Mitochondrial Proteins/metabolism; Molecular Chaperones/genetics; Parkinson Disease/genetics/metabolism/physiopathology; Reactive Oxygen Species/metabolism
Abstract :
[en] The mitochondrial chaperone mortalin has been linked to neurodegeneration in Parkinson's disease (PD) based on reduced protein levels in affected brain regions of PD patients and its interaction with the PD-associated protein DJ-1. Recently, two amino acid exchanges in the ATPase domain (R126W) and the substrate-binding domain (P509S) of mortalin were identified in Spanish PD patients. Here, we identified a separate and novel variant (A476T) in the substrate-binding domain of mortalin in German PD patients. To define a potential role as a susceptibility factor in PD, we characterized the functions of all three variants in different cellular models. In vitro import assays revealed normal targeting of all mortalin variants. In neuronal and non-neuronal human cell lines, the disease-associated variants caused a mitochondrial phenotype of increased reactive oxygen species and reduced mitochondrial membrane potential, which were exacerbated upon proteolytic stress. These functional impairments correspond with characteristic alterations of the mitochondrial network in cells overexpressing mutant mortalin compared with wild-type (wt), which were confirmed in fibroblasts from a carrier of the A476T variant. In line with a loss of function hypothesis, knockdown of mortalin in human cells caused impaired mitochondrial function that was rescued by wt mortalin, but not by the variants. Our genetic and functional studies of novel disease-associated variants in the mortalin gene define a loss of mortalin function, which causes impaired mitochondrial function and dynamics. Our results support the role of this mitochondrial chaperone in neurodegeneration and underscore the concept of impaired mitochondrial protein quality control in PD.
Research center :
- Luxembourg Centre for Systems Biomedicine (LCSB): Clinical & Experimental Neuroscience (Krüger Group)
Disciplines :
Genetics & genetic processes
Author, co-author :
Burbulla, Lena F.
Schelling, Carina
Kato, Hiroki
Rapaport, Doron
Woitalla, Dirk
Schiesling, Carola
Schulte, Claudia
Sharma, Manu
Illig, Thomas
Bauer, Peter
Jung, Stephan
Nordheim, Alfred
Schols, Ludger
Riess, Olaf
Krüger, Rejko ;  University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit
More authors (5 more) Less
Language :
Title :
Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis.
Publication date :
Journal title :
Human Molecular Genetics
Publisher :
Oxford University Press, United Kingdom
Volume :
Issue :
Pages :
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBilu :
since 28 June 2014


Number of views
99 (4 by Unilu)
Number of downloads
1 (1 by Unilu)

Scopus citations®
Scopus citations®
without self-citations
WoS citations


Similar publications

Contact ORBilu